Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
Supplemental Data
Supplemental Data
Files in this Data Supplement:
Supplemental Data
- Supplemental Tables 1 to 3